Understand the normal functions of RAS for better drug targeting

Our research is focused on the major oncogene RAS. We study how RAS isoforms fundamentally impact on differentiation and stemness during cell differentiation and in cancer. We identify novel RAS drug targeting mechanisms and are developing proof-of-concept drugs. We employ quantitative fluorescence imaging, flow cytometry, biochemical and cellular assay development and molecular cell biology.
Head of Group
